
    
      Study Design (Methodology):

      This will be a single center, open-label, randomised, phase IV, exploratory interventional
      study to compare the efficacy and tolerability of current titration patterns and slow
      titration pattern with TarginÂ® (Oxycodone/Naloxone) in the treatment of moderate to severe
      non-malignant chronic pain patients who are dissatisfied with their current analgesic
      medication World Health Organisation (WHO) step II analgesics).

      Upon providing written informed consent, subject will be screened in the study and assessment
      will be performed at that time such as safety laboratory assessments, physical examination,
      vital sign, medical history taking, 24 hours pain intensity score. If the patient is eligible
      in inclusion/exclusion criteria at the time of visit 1, the patient will be randomized in a
      1:1 ratio to allocate in Group A or Group B. Re-screening, study drug dose interruption is
      not allowed.
    
  